2014 fda drug approvals
TRANSCRIPT
![Page 1: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/1.jpg)
36 DRUGS
10 COMPANIESDRUGS
2014 YEAR IN REVIEW
FDADRUG APPROVALS
Novel Drugs Approved in 2014
APPROVED
![Page 2: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/2.jpg)
Type 2 Diabetes
Source: FDA.GOV
FARXIGA 1
![Page 3: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/3.jpg)
Non24Hour SleepWake Disorder
Source: FDA.GOV
HETLIOZ 2
![Page 4: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/4.jpg)
Morquio A Syndrome
Source: FDA.GOV
VIMIZIM 3
![Page 5: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/5.jpg)
Neurogenic Orthostatic Hypotension(NOH)
Source: FDA.GOV
NORTHERA 4
![Page 6: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/6.jpg)
Complications of Leptin Deficiency
Source: FDA.GOV
MYALEPT 5
![Page 7: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/7.jpg)
Positron Emission Tomography (PET)Imaging of the Brain
Source: FDA.GOV
NEURACEQ 6
![Page 8: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/8.jpg)
Leishmaniasis
Source: FDA.GOV
IMPAVIDO 7
![Page 9: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/9.jpg)
Moderate to Severe Plaque Psoriasis
Source: FDA.GOV
OTEZLA 8
![Page 10: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/10.jpg)
Type 2 Diabetes
Source: FDA.GOV
TANZEUM 9
![Page 11: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/11.jpg)
Advanced Stomach Cancer orGastroesophageal JunctionAdenocarcinoma
Source: FDA.GOV
CYRAMZA 10
![Page 12: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/12.jpg)
Multicentric Castleman’s Disease (MCD)
Source: FDA.GOV
SYLVANT 11
![Page 13: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/13.jpg)
Anaplastic Lymphoma KinasePositive(ALK+) Metastatic NonSmall Cell LungCancer (NSCLC)
Source: FDA.GOV
ZYKADIA 12
![Page 14: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/14.jpg)
Reduce Risk of Heart Attacks and Stroke inHighRisk Patients
Source: FDA.GOV
ZONTIVITY 13
![Page 15: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/15.jpg)
Severe Ulcerative Colitis and AdultPatients with Moderate to Severe Crohn‘sDisease
Source: FDA.GOV
ENTYVIO 14
![Page 16: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/16.jpg)
Acute Bacterial Skin and Skin StructureInfections
Source: FDA.GOV
DALVANCE 15
![Page 17: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/17.jpg)
Toenail Fungus
Source: FDA.GOV
JUBLIA 16
![Page 18: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/18.jpg)
Acute Bacterial Skin and Skin StructureInfections
Source: FDA.GOV
SIVEXTRO 17
![Page 19: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/19.jpg)
Peripheral TCell Lymphoma (PTCL)
Source: FDA.GOV
BELEODAQ 18
![Page 20: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/20.jpg)
Toenail Fungus
Source: FDA.GOV
KERYDIN 19
![Page 21: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/21.jpg)
Chronic Lymphocytic Leukemia (CLL)Follicular Bcell nonHodgkin Lymphoma(FL)Small Lymphocytic Lymphoma (SLL)
Source: FDA.GOV
ZYDELIG 20
![Page 22: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/22.jpg)
Chronic Obstructive Pulmonary Disease(COPD)
Source: FDA.GOV
STRIVERDIRESPIMAT
21
![Page 23: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/23.jpg)
Type 2 Diabetes
Source: FDA.GOV
JARDIANCE 22
![Page 24: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/24.jpg)
Type 2 Diabetes
Source: FDA.GOV
ORBACTIV 23
![Page 25: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/25.jpg)
Insomnia
Source: FDA.GOV
BELSOMRA 24
![Page 26: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/26.jpg)
Relapsing Forms of Multiple Sclerosis (MS)
Source: FDA.GOV
PLEGRIDY 25
![Page 27: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/27.jpg)
Gaucher Disease Type 1
Source: FDA.GOV
CERDELGA 26
![Page 28: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/28.jpg)
Melanoma
Source: FDA.GOV
KEYTRUDA 27
![Page 29: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/29.jpg)
OpioidInduced Constipation (OIC) in AdultPatients with Chronic Non‑Cancer Pain
Source: FDA.GOV
MOVANTIK 28
![Page 30: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/30.jpg)
Type 2 Diabetes
Source: FDA.GOV
TRULICITY 29
![Page 31: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/31.jpg)
Type 2 Diabetes
Source: FDA.GOV
LUMASON 30
![Page 32: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/32.jpg)
Nausea and Vomiting in PatientsUndergoing Cancer Chemotherapy
Source: FDA.GOV
AKYNZEO 31
![Page 33: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/33.jpg)
Chronic Hepatitis C
Source: FDA.GOV
HARVONI 32
![Page 34: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/34.jpg)
Idiopathic Pulmonary Fibrosis (IPF)
Source: FDA.GOV
ESBRIET 33
![Page 35: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/35.jpg)
Idiopathic Pulmonary Fibrosis (IPF)
Source: FDA.GOV
OFEV 34
![Page 36: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/36.jpg)
Acute Lymphoblastic Leukemia
Source: FDA.GOV
BLINCYTO 35
![Page 37: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/37.jpg)
Otitis Externa (Swimmer's Ear)
Source: FDA.GOV
XTORO 36
![Page 38: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/38.jpg)
Advanced Ovarian Cancer
Source: FDA.GOV
LYNPARZA 37
![Page 39: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/39.jpg)
Chronic Genotype 1 Hepatitis C
Source: FDA.GOV
VIEKIRA PAK 38
![Page 40: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/40.jpg)
COMPLICATED URINARY TRACT ANDCOMPLICATED INTRAABDOMINALINFECTIONS
Source: FDA.GOV
ZERBAXA 39
![Page 41: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/41.jpg)
Acute Uncomplicated Influenza
Source: FDA.GOV
RAPIVAB 40
![Page 42: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/42.jpg)
Advanced Melanoma
Source: FDA.GOV
OPDIVO 41
![Page 43: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/43.jpg)
Chronic Weight Management
Source: FDA.GOV
SAXENDA 42
![Page 44: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/44.jpg)
Chronic Lymphocytic Leukemia
Source: FDA.GOV
IMBRUVICA 43
![Page 45: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/45.jpg)
Type 2 Diabetes
Source: FDA.GOV
INVOKAMET 44
![Page 46: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/46.jpg)
Inflammatory Lesions, Bumps andPimples, of Rosacea
Source: FDA.GOV
SOOLANTRA 45
![Page 47: 2014 FDA Drug Approvals](https://reader034.vdocument.in/reader034/viewer/2022042607/55a0cebe1a28ab20728b4570/html5/thumbnails/47.jpg)
36 DRUGS
10 COMPANIES
DRUGS
CREATED BY: